COMFORTIS (spinosad) is available in six sizes of chewable flavored tablets for oral administration to dogs and puppies according to their weight. Each chewable tablet is formulated to provide a minimum spinosad dosage of 13.5 mg/lb (30 mg/kg).
The IQ-achievement discrepancy model assesses whether there is a significant difference between a studentâs scores on a test of general intelligence (e.g., an IQ test such as the WISC-IV) and scores obtained on an achievement test (e.g., the Woodcock Johnson Achievement Test).
The IQ-discrepancy criterion is potentially harmful to students as it results in delaying intervention until the studentâs achievement is sufficiently low that the discrepancy is achieved. â¦ the âwait to failâ model does not lead to âclosing the achievement gap for most students placed in special education.